Breast cancer screening: Characteristics and results of the Spanish programs;Programas de detección precoz de cáncer de mama en España: características y principales resultados

Medicina Clinica

Volumn 141, Issue 1, 2013, Pages 13-23

  Ascunce, Nieves ^a   Delfrade, Josu ^a   Salas, Dolores ^b   Zubizarreta, Raquel ^c   Ederra, María ^a  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b Foundation for the Promotion of Health and Biomedical Research of Valencia Region   (Spain)

^c Dirección Xeral de Saúde Pública   (Spain)

Author keywords

Breast cancer; Performance indicators; Results; Screening; Spain

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; FEMALE; GROUPS BY AGE; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; REFERENCE VALUE; SPAIN; TUMOR INVASION;

AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; EARLY DETECTION OF CANCER; FEMALE; GOVERNMENT PROGRAMS; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROGRAM EVALUATION; SPAIN;

EID: 84879311906     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2012.03.030     Document Type: Article

References (34)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. M.J. Sánchez, T. Payer, R. De Angelis, N. Larrañaga, R. Capocaccia, C. Martinez for the CIBERESP Working Group Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012 Ann Oncol 21 Suppl. 3 2010 iii30 iii36
3. M.P. Madigan, R.G. Ziegler, J. Benichou, C. Byrne, and R.N. Hoover Proportion of breast cancer cases in the United States explained by well-established risk factors J Natl Cancer Inst 87 1995 1681 1685
4. Breast Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 7. Lyon: IARC Press; 2002.
5. M. Hakama, M.P. Coleman, D.M. Alexe, and A. Auvinen Cancer screening: evidence and practice in Europe 2008 Eur J Cancer 44 2008 1404 1413
6. D. Schopper, and C. de Wolf How effective are breast cancer screening programmes by mammography? Review of the current evidence Eur J Cancer 45 2009 1916 1923
7. R. Gabe, and S.W. Duffy Evaluation of service screening mammography in practice: the impact on breast cancer mortality Ann Oncol 16 Suppl. 2 2005 ii153 ii162
8. Council Recommendation of 2 December on Cancer Screening Off J Eur Union 878 2003 34 38
9. N. Perry, M. Broeders, C. de Wolf, S. Törnberg, R. Holland, and L. von Karsa European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. European Commission 4th ed 2006 Office for Official Publications of the European Communities Luxembourg
10. L. Von Karsa, A. Anttila, G. Ronco, A. Ponti, N. Malila, and M. Arbyn Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening-First Report 2008 Services of the European Commission Luxembourg
11. Estrategia en cáncer del Sistema Nacional de Salud. Actualización 2009. Madrid: Ministerio de Sanidad y Política Social; 2010.
12. N. Ascunce Elizaga, L. Salas Trejo, R. Zubizarreta Alberdi, and J.L. Aboal Viñas Coordinación. La experiencia de la red de los programas de detección precoz de cáncer de mama Rev Adm Sanit 6 2008 95 105
13. Red de programas de cribado de cáncer [consultado 18 Dic 2011]. Disponible en: http://www.cribadocancer.es
14. N.E. Day, D.R. Williams, and K.T. Khaw Breast cancer screening programmes: the development of a monitoring and evaluation system Br J Cancer 59 1989 954 958
15. M. Broeders, L. Nyström, N. Ascunce, E. Riza, N. Becker, and S. Törnberg Epidemiological guidelines for quality assurance in breast cancer screening European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. European Commission 4th ed 2006 Office for Official Publications of the European Communities Luxembourg
16. Cancer Incidence in Five Continents. Vol. VII (n. 143), VIII (n. 155) and IX (n. 160). Lyon: IARC Scientific Publications; 1997, 2002, 2007.
17. Castells X, Sala M, Ascunce N, Salas D, Zubizarreta R, Casamitjana M. Descripción del cribado del cáncer en España. Proyecto DESCRIC. Informes de Evaluación de Tecnologías Sanitarias, AATRM núm. 2006/01.Madrid: Plan de Calidad para el Sistema Nacional de Salud. Ministerio de Sanidad y Consumo. Agència d'Avaluació de Tecnologia i Recerca Mèdiques de Cataluña; 2007.
18. N. Ascunce, D. Salas, R. Zubizarreta, R. Almazán, J. Ibáñez, and M. Ederra Cancer screening in Spain Ann Oncol 21 Suppl. 3 2010 iii43 iii51 10.1093/annonc/mdq085
19. M.J. Broeders, A. Scharpantgen, N. Ascunce, B. Gairard, A.H. Olsen, and P. Mantellini Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000 Eur J Cancer Prev 14 2005 107 116
20. E. Regidor, B. Sanz, C. Pascual, L. Lostao, E. Sánchez, and J.M. Díaz Olalla La utilización de los servicios sanitarios por la población inmigrante en España Gac Sanit 23 Suppl. 1 2009 4 11
21. C. Borrell, L. Palència, M. Rodríguez-Sanz, D. Malmusi, X. Bartoll, and R. Puigpinós Evolución de las desigualdades sociales en salud en Cataluña Med Clin (Barc) 137 Suppl. 2 2011 60 65
22. M. Pollán, R. Pastor-Barriuso, E. Ardanaz, M. Argüelles, C. Martos, and J. Galcerán Recent changes in breast cancer incidence in Spain, 1980-2004 J Natl Cancer Inst 101 2009 1584 1591
23. A. Izquierdo, J.R. González, V. Moreno, J. Galceran, R. Marcos-Gragera, and R. Clèries Incidencia del cáncer de mama en Cataluña: análisis de la tendencia Med Clin (Barc) 126 2006 286 289
24. B.C. Yankaskas, C.N. Klabunde, R. Ancelle-Park, G. Renner, H. Wang, J. Fracheboud International Breast Cancer Screening Network International comparison of performance measures for screening mammography: can it be done? J Med Screen 11 2004 187 193
25. R. Román, M. Sala, D. Salas, N. Ascunce, R. Zubizarreta, and X. Castells Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening Ann Oncol 23 2012 104 111
26. R. Zubizarreta, A.B. Fernández Llanes, R. Almazán Ortega, R. Román, J.M. Velarde Collado, and T. Queiro Verdes Effect of radiologist experience on the risk of false-positive results in breast cancer screening programs Eur Radiol 21 2011 2083 2090
27. R. Román, M. Sala, M. de la Vega, C. Natal, J. Galceran, and I. González-Román Effect of false-positives and women's characteristics on long-term adherence to breast cancer screening Breast Cancer Res Treat 130 2011 543 552
28. I. Martínez-Pino, T. Puig, M.J. Quintana, J. Sol, and X. Bonfill Prevalencia de tratamiento hormonal sustitutivo en mujeres que participan en un programa de cribado de cáncer de mama Med Clin (Barc) 134 2010 439 442
29. L. Domingo, M. Sala, S. Servitja, J.M. Corominas, F. Ferrer, and J. Martínez Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain Cancer Causes Control 21 2010 1155 1164
30. A. Cabanes, E. Vidal, N. Aragonés, B. Pérez-Gómez, M. Pollán, and V. Lope Cancer mortality trends in Spain: 1980-2007 Ann Oncol 21 Suppl. 3 2010 iii14 iii20 10.1093/annonc/mdq089
31. A. Cabanes, E. Vidal, B. Pérez-Gómez, N. Aragonés, G. López-Abente, and M. Pollán Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006 Cancer Epidemiol 33 2009 169 175
32. A. Izquierdo, R. Gispert, F. Saladie, and J.A. Espinàs Análisis de la incidencia, la supervivencia y la mortalidad según las principales localizaciones tumorales, 1985-2019: cáncer de mama Med Clin (Barc) 131 Suppl. 1 2008 50 52
33. M.D. Ugarte, T. Goicoa, J. Etxeberria, A.F. Militino, and M. Pollán Age-specific spatio-temporal patterns of female breast cancer mortality in Spain (1975-2005) Ann Epidemiol 20 2010 906 916
34. N. Ascunce, C. Moreno-Iribas, A. Barcos, E. Ardanaz, M. Ederra, and J. Castilla Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme J Med Screen 14 2007 14 20